Cahir Marie, King David J
Department of Mental Health, The Queen's University of Belfast, Whitla Medical Building, 97 Lisburn Rd., Belfast BT9 7BL, UK.
Eur Neuropsychopharmacol. 2005 Mar;15(2):231-4. doi: 10.1016/j.euroneuro.2004.10.002.
The alpha1A- and alpha1B-adrenoceptor affinity of the typical (chlorpromazine, haloperidol, pimozide, thioridazine and trifluoperazine) and atypical (clozapine, olanzapine, quetiapine, risperidone and sertindole) antipsychotics was determined by competition binding at alpha1A- and alpha1B-adrenoceptors in rat submaxillary gland and liver. Although all antipsychotics bound to both subtypes with relatively high affinity (K(i)s<74 nM), none were selective (>10-fold). Comparison with published dopamine D2 receptor affinities suggests that antipsychotic blockade of alpha1A- and/or alpha1B-adrenoceptors may contribute to the antipsychotic activity of all the atypical and several of the typical antipsychotics examined.
通过在大鼠颌下腺和肝脏中α1A - 和α1B - 肾上腺素能受体上的竞争结合实验,测定了典型抗精神病药物(氯丙嗪、氟哌啶醇、匹莫齐特、硫利达嗪和三氟拉嗪)和非典型抗精神病药物(氯氮平、奥氮平、喹硫平、利培酮和舍吲哚)对α1A - 和α1B - 肾上腺素能受体的亲和力。尽管所有抗精神病药物都以相对较高的亲和力(K(i)s < 74 nM)与这两种亚型结合,但没有一种具有选择性(> 10倍)。与已发表的多巴胺D2受体亲和力比较表明,抗精神病药物对α1A - 和/或α1B - 肾上腺素能受体的阻断作用可能有助于所有检测的非典型抗精神病药物以及几种典型抗精神病药物的抗精神病活性。